9R6T | pdb_00009r6t

Prefusion stabilized spike glycoprotein of equine coronavirus.


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.76 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

Starting Model: in silico
View more details

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

AI-guided prefusion stabilization of the human coronavirus OC43 spike protein enables universal embecovirus antigen design.

Melchers, J.M.Juraszek, J.Hulswit, R.J.G.van Overveld, D.Le, L.van Kuppeveld, F.J.M.Hurdiss, D.L.Bosch, B.J.Langedijk, J.P.M.Bakkers, M.J.G.

(2026) PLoS Pathog 22: e1013998-e1013998

  • DOI: https://doi.org/10.1371/journal.ppat.1013998
  • Primary Citation Related Structures: 
    9R6S, 9R6T

  • PubMed Abstract: 

    The continued threat of zoonotic coronavirus spillovers underscores the need for cross-species applicable vaccine design strategies. The genus Embecovirus includes human coronaviruses OC43 and HKU1 as well as relevant veterinary pathogens. The coronavirus spike (S) fusion glycoprotein, key to viral entry and protective immunity, is inherently metastable, complicating vaccine development. Using the ReCaP AI tool, we stabilized the prefusion conformation of OC43 S through rationally combined amino acid substitutions, resulting in markedly enhanced expression and thermal stability. The substitutions were transferable to equine coronavirus (ECoV) S and HKU1. Cryo-EM structures of stabilized OC43 and ECoV S revealed that stabilization was achieved by arresting the release of the fusion peptide and keeping the S1B receptor binding domain in the 'down' state by improving the complex polar interactions of neighboring S1B domains and the bound free fatty acid at the interprotomer S1B interface. This work provides the first ECoV S structure and a broadly applicable framework for engineering stabilized Embecovirus S antigens.


  • Organizational Affiliation
    • Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Spike glycoprotein
A, B, C
1,302Equine coronavirusMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Glycosylation
Glycosylation Sites: 13
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
8Z9 (Subject of Investigation/LOI)
Query on 8Z9

Download Ideal Coordinates CCD File 
IA [auth A],
NA [auth B],
OA [auth C]
Sapienic acid
C16 H30 O2
NNNVXFKZMRGJPM-KHPPLWFESA-N
NAG
Query on NAG

Download Ideal Coordinates CCD File 
EA [auth A]
FA [auth A]
GA [auth A]
HA [auth A]
JA [auth B]
EA [auth A],
FA [auth A],
GA [auth A],
HA [auth A],
JA [auth B],
KA [auth B],
LA [auth B],
MA [auth B],
PA [auth C],
QA [auth C],
RA [auth C],
SA [auth C]
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.76 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
EM Software:
TaskSoftware PackageVersion
MODEL REFINEMENTPHENIX1.20.1_4487:
RECONSTRUCTIONcryoSPARC

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Other privateNetherlands--

Revision History  (Full details and data files)

  • Version 1.0: 2026-03-11
    Type: Initial release
  • Version 1.1: 2026-04-01
    Changes: Data collection, Database references